ABOUT ACTIGRAPH
ActiGraph is pioneering the digital transformation of clinical research. We provide end-to-end digital health technology (DHT) solutions by integrating and operationalizing the best hardware, software, and algorithms to generate reliable evidence and get the right treatments to the right patients, faster. ActiGraph’s medical-grade wearable technology platform has been used to capture real-world, continuous digital measures for nearly 200 industry-sponsored clinical trials and thousands of academic research studies. Appearing in over 20,000 published scientific papers to date, ActiGraph is the most experienced and trusted wearable technology partner in the industry.
DIGITAL ENDPOINTS LIBRARY
-
Explore how sensor-based digital health technologies can revolutionize the treatment and management of movement disorders by providing more accurate, patient-centered outcomes.
-
Find out how sensor-based digital health technologies (DHTs) offer direct, objective daily life assessments, accelerating NMD drug development.
-
Explore how digital health technologies can enhance obesity treatment by providing critical insights beyond weight loss.
-
Discover how recent advancements in wearable sensors and data science have provided the opportunities for objective and unobtrusive assessment of walking in the real world.
-
People with cancer emphasize quality of life (QOL) as an important health outcome across their journey. Explore how digital health technologies can collect patient-centric outcomes passively and remotely, minimizing the burden for people to participate in clinical trials.
-
Explore how an objective scratch measure is now achievable through the use of wrist-worn wearable technology that is both non-invasive and easy to implement.
-
Drug development in neurology is notoriously challenging. Despite being one of the most active areas of clinical development, neurological disease drug trials have among the longest development timelines and highest failure rates in the industry. Learn more in the available e-Book.
-
Wearable devices provide a low-burden and remote approach to quantifying people’s sleep. While difficult to estimate, learn how actigraphy is sensitive to treatment effects.
CONTACT INFORMATION
ActiGraph
70 N Baylen St, Suite 400
Pensacola, FL 32502
UNITED STATES
Phone: 850.332.7900
Contact: Genevieve Baley
SOLUTIONS
FEATURED ARTICLES
- Demystifying AI: A Review Of The Fundamentals And Applications In Drug Development
- Digital Endpoint Resource Guide: Parkinson's Disease
- Digital Measures To Advance Research And Quality Of Life In Schizophrenia
- Digital Endpoint Resource Guide: Obesity And Related Metabolic Disorders
- Wearable DHT 101: Foundations For Use In Regulated Clinical Trials
- Improving Patient Outcomes With Wearables In Major Depressive Disorder
- Database To Advance Patient-Focused Drug Development With DHTs
- Enhancing Activity And Gait Monitoring In Children Using DHTs
- Looking Beyond Weight Loss In The Obesity Pandemic: What's Next?
- Advancing Patient-Centric Research With DHTs
- Unveiling The Critical Role of Sleep In Clinical Studies
- Advancing ALS Research With Digital Health Technologies
- Planning Ahead: 5 Best Practices For The Integration Of Wearables
- Closing The Gap In Our Understanding Of Sleep Health With DHTs
- Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch
- Navigating Wearable Integration: Key Operational Considerations
- Digital Endpoint Resource Guide: Rheumatology
- Digital Endpoint Resource Guide: Neuromuscular Disorders
- How Can Digital Measures Advance Heart Failure Research?
- Developing A Patient-Centric Measure Of Nocturnal Scratch